Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $171.98 USD
Change Today -3.30 / -1.88%
Volume 2.2M
ALXN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alexion pharmaceuticals inc (ALXN)

Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
NET INCOME175.3254.8252.9656.9
Depreciation & Amortization8.611.015.928.8
Amortization of Goodwill and Intangible Assets5.15.78.311.2
DEPRECIATION & AMORTIZATION, TOTAL13.716.624.239.9
Amortization of Deferred Charges3.97.34.57.0
(Gain) Loss on Sale of Investment0.0--3.215.5
Asset Writedown & Restructuring Costs--26.333.511.5
Other Operating Activities49.672.998.9-111.6
Tax Benefit from Stock Options---7.2-105.7-251.1
Change in Accounts Receivable-78.8-72.9-116.4-28.1
Change in Inventories-12.2-6.30.1-66.8
Change in Accounts Payable79.869.0242.4264.6
Change in Unearned Revenues15.013.223.56.2
Change in Other Working Capital-21.0-17.0-39.9-18.4
CASH FROM OPERATIONS270.1410.6497.3640.1
Capital Expenditure-22.0-21.8-29.3-136.6
Cash Acquisitions-105.9-605.7----
Investments in Marketable & Equity Securities94.5---988.5-85.7
CASH FROM INVESTING-33.7-627.6-1,027.1-222.9
Short-Term Debt Issued60.0115.0----
Long-Term Debt Issued--240.0----
TOTAL DEBT ISSUED60.0355.0----
Short Term Debt Repaid-60.0-115.0----
Long Term Debt Repaid---91.0-36.0-55.5
TOTAL DEBT REPAID-60.0-206.0-36.0-55.5
Issuance of Common Stock35.8528.771.3114.4
Repurchase of Common Stock---11.6-66.1-302.6
Other Financing Activities3.30.3102.5250.9
CASH FROM FINANCING39.1666.471.67.1
Foreign Exchange Rate Adjustments-1.7-0.8-1.5-10.2
NET CHANGE IN CASH273.7448.6-459.6414.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $171.98 USD -3.30

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,799 GBp -57.00
Dr Reddy's Laboratories Ltd 4,053 INR 0.00
Sigma-Aldrich Corp $139.46 USD -0.10
Symrise AG €52.41 EUR -0.80
United Therapeutics Corp $149.21 USD -0.75
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 59.9x
Price/Sales 14.8x
Price/Book 4.6x
Price/Cash Flow 66.9x
TEV/Sales 14.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.